Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 8.8% in December

Cibus, Inc. (NASDAQ:CBUS) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 2,230,000 shares, an increase of 8.8% from the November 30th total of 2,050,000 shares. Based on an average daily trading volume, of 168,500 shares, the short-interest ratio is presently 13.2 days. Approximately 11.9% of the shares of the stock are short sold.

Analysts Set New Price Targets

Several analysts recently commented on CBUS shares. HC Wainwright reaffirmed a “buy” rating and issued a $25.00 price target on shares of Cibus in a research note on Monday, November 11th. Canaccord Genuity Group restated a “buy” rating and issued a $20.00 target price on shares of Cibus in a research note on Tuesday, October 22nd. Finally, Alliance Global Partners dropped their target price on shares of Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research report on Tuesday, September 24th.

Cibus Price Performance

NASDAQ CBUS opened at $2.78 on Thursday. The stock’s 50 day simple moving average is $4.01 and its 200 day simple moving average is $5.81. Cibus has a one year low of $2.35 and a one year high of $23.18. The firm has a market cap of $73.55 million, a PE ratio of -0.12 and a beta of 1.86.

Hedge Funds Weigh In On Cibus

Institutional investors and hedge funds have recently bought and sold shares of the business. SG Americas Securities LLC acquired a new stake in shares of Cibus in the third quarter valued at $33,000. B. Riley Wealth Advisors Inc. bought a new stake in Cibus during the 3rd quarter worth about $44,000. Virtu Financial LLC acquired a new stake in Cibus in the 3rd quarter valued at about $48,000. HighTower Advisors LLC raised its stake in shares of Cibus by 20.6% in the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock worth $52,000 after acquiring an additional 2,750 shares during the last quarter. Finally, Barclays PLC lifted its position in shares of Cibus by 287.2% during the third quarter. Barclays PLC now owns 20,269 shares of the company’s stock worth $66,000 after purchasing an additional 15,034 shares in the last quarter. Institutional investors and hedge funds own 33.81% of the company’s stock.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.